Untitled attachment

Notices where this attachment appears

1. Embed this notice
   Dr Alex 🩺🚼 (alexped@mastodon.uno)'s status on Thursday, 14-Dec-2023 17:25:28 JST Dr Alex 🩺🚼

   Continued Progress in the Development of Safe and Effective #RSV Immunizations

   📌 Before 2023, there were no immunizing tools to protect older adults and all infants from illness due to respiratory syncytial virus (RSV).

   📌 In 2023, two RSV vaccines for older adults, one of which is also approved for use in pregnant persons, and a long-acting monoclonal antibody to protect infants and some toddlers up to 19 months of age were approved by FDA and recommended by the ACIP

   https://www.nejm.org/doi/pdf/10.1056/NEJMe2311862?articleTools=true